Prime Medicine, Inc. Shares Outstanding (Cover Page)
Prime Medicine, Inc. (PRME) had Shares Outstanding (Cover Page) of 181.38 million shares as of 2026-07-31, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-07-31: Entity Common Stock, Shares Outstanding 181.38M shares.
- 2026-04-30: Entity Common Stock, Shares Outstanding 180.62M shares.
- 2026-02-20: Entity Common Stock, Shares Outstanding 180.55M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 180.51M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 181.38M shares 10-Q · filed 2026-08-06 |
| 2026-04-30 | 180.62M shares 10-Q · filed 2026-05-07 |
| 2026-02-20 | 180.55M shares 10-K · filed 2026-03-03 |
| 2025-10-31 | 180.51M shares 10-Q · filed 2025-11-07 |
| 2025-07-31 | 134.57M shares 10-Q · filed 2025-08-07 |
| 2025-04-30 | 131.29M shares 10-Q · filed 2025-05-08 |
| 2025-02-20 | 131.16M shares 10-K · filed 2025-02-28 |
| 2024-10-31 | 131.16M shares 10-Q · filed 2024-11-12 |
| 2024-08-01 | 120.03M shares 10-Q · filed 2024-08-08 |
| 2024-05-01 | 120.03M shares 10-Q · filed 2024-05-10 |
| 2024-02-23 | 119.94M shares 10-K · filed 2024-03-01 |
| 2023-10-31 | 97.32M shares 10-Q · filed 2023-11-03 |
| 2023-07-31 | 97.30M shares 10-Q · filed 2023-08-07 |
| 2023-04-28 | 97.23M shares 10-Q · filed 2023-05-11 |
| 2023-03-07 | 97.25M shares 10-K · filed 2023-03-09 |
| 2022-11-08 | 97.21M shares 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B |